State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc’s China drug distribution business for $557 million, as it seeks to expand its distribution and retail network nationwide.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
